A study presented on Feb. 6 at the American Stroke Association’s International Stroke Conference finds that stroke survivors who take cilostazol in combination with aspirin or clopidogrel have less risk of a recurrent stroke compared with those who take aspirin or clopidogrel alone.Read more via American Heart Association Newsroom.